Experience

Davis Polk is advising McKesson Corporation on its acquisition of Medical Specialties Distributors, LLC from New Mountain Capital. The transaction is valued at $800 million, and is subject…

Davis Polk advised Notre Dame Intermédica Participações S.A. in connection with the initial public offering by Notre Dame Intermédica and by Bain Capital, the controlling shareholder of…

Davis Polk advised Sumitomo Mitsui Banking Corporation in connection with its reopening of its January 2018 senior debt takedown offering issued under its global medium-term notes program…

Davis Polk advised the joint book-running managers on a Rule 144A/Regulation S offering by TopBuild Escrow Corp., a wholly owned subsidiary of TopBuild Corp., of $400 million aggregate…

Davis Polk advised Freeport-McMoRan Inc. (“FCX”), PT Freeport Indonesia (“PTFI”), a subsidiary of FCX, and Freeport-McMoRan Oil & Gas LLC (“FM O&G”) in connection with a $3.5…

Davis Polk advised the initial purchasers in connection with the $300 million Regulation S offering by Central China Real Estate Limited of its 6.875% senior notes due 2020.  CCRE…

Davis Polk advised the initial purchasers in connection with the U.S. dollar issuance of senior non-preferred notes by Crédit Agricole S.A., acting through its London branch. Under its…

Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $3.75 billion aggregate principal amount of senior notes, consisting of $2.75 billion fixed-to…

Davis Polk advised Pivotal Software, Inc. on its SEC-registered initial public offering of 42,550,000 shares of Class A common stock, including the full exercise by the underwriters of…

Davis Polk advised the joint book-running managers in connection with a $36 million SEC-registered common stock offering by Aeglea BioTherapeutics, Inc. The common stock is listed on…